- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02747160
Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention
October 9, 2020 updated by: Memorial Sloan Kettering Cancer Center
Evaluation of an Anxiety Intervention for Older Adults With Cancer and Informal Caregivers of Older Adults With Cancer
The purpose of this study is to examine the feasibility and acceptability of and patient adherence to a telephone-administered cognitive-behavioral therapy intervention for anxiety in older adults (65 years and older) with cancer and their primary informal caregiver.
This study will also examine whether the intervention has a clinically significant impact on patient anxiety (primary outcome) and depression, distress, and quality of life (secondary outcomes).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a single arm pre-post evaluation of a six-session telephone-administered cognitive-behavioral therapy (CBT) intervention for anxiety in older adults with cancer and their primary informal (unpaid) caregiver.
The primary purposes of this study are to evaluate the feasibility of the intervention and study procedures, acceptability of the intervention to older adults with cancer and their primary informal caregiver, and patient and caregiver adherence to the intervention.
The secondary purpose is to examine changes in patient and caregiver anxiety, depression, distress, and quality of life pre to post intervention to determine whether the intervention has a clinically significant impact on these outcomes.
Anxiety is the primary outcome; depression, distress, and quality of life are secondary outcomes.
Patients will be 65 years of age or older and will be recruited from the myeloma, lung, lymphoma, gynecologic, and gastrointestinal cancer clinics at a single institution.
Study measures will be administered by telephone prior to initiating the intervention (pre-intervention) and following intervention completion (post-intervention).
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Weill Medical College of Cornell University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient age 65 years or older
- Diagnosis of cancer
- Patient and/or caregiver score of 8 or higher on the anxiety subscale of the Hospital Anxiety and Depression Scale
- A primary informal caregiver who is willing and able to participate
- Patient and caregiver are able to communicate over the telephone
- Caregiver is age 21 years or older.
Exclusion Criteria:
- Patient or caregiver is not fluent in English
- Patient or caregiver is too weak or cognitively impaired to participate in the intervention
- Patient or caregiver has received CBT since the patient's cancer diagnosis
- Patient or caregiver has an active major psychiatric condition such as schizophrenia
- Patient only experiences anxiety in the context of a specific medical procedure
- Patient or caregiver endorses active suicidal ideation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Managing Anxiety from Cancer (MAC)
Older adults with cancer and their primary informal caregiver will receive a six-session cognitive-behavior therapy intervention administered over the telephone by a trained study interventionist.
The intervention is administered weekly and each session is 45-50 minutes in length.
Patients and caregivers will receive the intervention independently and from separate therapists.
|
The intervention consists of six telephone-administered sessions.
Session topics include psychoeducation on anxiety, behavioral strategies for managing anxiety, cognitive restructuring, communication skills training, acceptance techniques (patient only), problem-solving strategies (caregiver only), and planning for future anxiety.
Session content is tailored for older adults and caregivers of older adults with cancer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention feasibility
Time Frame: Post-intervention (6-8 weeks after baseline)
|
Attrition rates
|
Post-intervention (6-8 weeks after baseline)
|
Intervention acceptability
Time Frame: Post-intervention (6-8 weeks after baseline)
|
Likert scale ratings of perceived helpfulness and readability of the intervention
|
Post-intervention (6-8 weeks after baseline)
|
Patient/caregiver adherence
Time Frame: Post-intervention (6-8 weeks after baseline)
|
Sum of number of intervention exercises completed with number of sessions completed by patients and caregivers
|
Post-intervention (6-8 weeks after baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in anxiety from baseline to post-intervention
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Anxiety sub-scale of the Hospital Anxiety and Depression Scale
|
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Change in distress from baseline to post-intervention
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Distress Thermometer
|
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Emotional health-related quality of life
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Functional Assessment of Cancer Therapy-General: Emotional Quality of Life Sub-Scale; Caregiver Quality of Life-Cancer
|
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Change in depression from baseline to post-intervention
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Depression sub-scale of the Hospital Anxiety and Depression Scale
|
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Kelly M Trevino, PhD, Weill Medical College of Cornell University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2016
Primary Completion (ACTUAL)
July 2, 2020
Study Completion (ACTUAL)
July 2, 2020
Study Registration Dates
First Submitted
April 12, 2016
First Submitted That Met QC Criteria
April 18, 2016
First Posted (ESTIMATE)
April 21, 2016
Study Record Updates
Last Update Posted (ACTUAL)
October 14, 2020
Last Update Submitted That Met QC Criteria
October 9, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-280
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
Clinical Trials on Managing Anxiety from Cancer (MAC)
-
Memorial Sloan Kettering Cancer CenterRecruitingCancer Patients | Care GiversUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institute on Aging (NIA); Weill Medical College of Cornell UniversityActive, not recruitingDepression | Quality of Life | AnxietyUnited States
-
University Health Network, TorontoActive, not recruiting
-
The Hospital for Sick ChildrenMcGill University; University of Alberta; McMaster University; Hamilton Health... and other collaboratorsCompleted
-
Yale UniversityIcahn School of Medicine at Mount SinaiCompletedFamily CaregiversUnited States
-
Virginia Commonwealth UniversityAmerican Cancer Society, Inc.Completed
-
University of LeipzigUniversity Health Network, Toronto; University of Hamburg-Eppendorf; German Cancer...CompletedDepression | Psychological DistressGermany
-
University Health Network, TorontoUniversity of UlmRecruiting
-
Silver Cloud HealthSumma Health SystemTerminatedDepressive Disorder | Depression | Anxiety DisordersUnited States
-
Silver Cloud HealthCompletedDepression | Stress | AnxietyUnited States